The new rules, which apply to transmucosal immediate-release fentanyl (TIRF) drugs, state that providers should prescribe TIRF drugs only to opioid-tolerant patients and require prescribers to document and verify the patient's opioid tolerance, in today's bite-sized hospital and health industry news from Maryland, New York, and Virginia.
Create your free account to access 2 resources each month, including the latest research and webinars.
You have 2 free members-only resources remaining this month remaining this month.
1 free members-only resources remaining this month
1 free members-only resources remaining this month
Never miss out on the latest innovative health care content tailored to you.